<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04388072</url>
  </required_header>
  <id_info>
    <org_study_id>LS2019-004-02</org_study_id>
    <nct_id>NCT04388072</nct_id>
  </id_info>
  <brief_title>An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit</brief_title>
  <official_title>An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Fujian Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The diagnostic cohort study could will be use to verify the clinical performance of the AQP4&#xD;
      -immunoglobulin G detection kit and whether it has a good correlation with the clinical&#xD;
      diagnosis results. The applicability and accuracy of the kit in clinical diagnosis will be&#xD;
      verified according to the measured data.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Actual">February 20, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>results of AQP4 -immunoglobulin G detection kit</measure>
    <time_frame>through study completion, an average of 6 months</time_frame>
    <description>The Serum test results of participants using AQP4 -immunoglobulin G detection kit</description>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Neuromyelitis Optica Spectrum Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with NMOSD who are diagnosied in the First Affiliated Hospital of Fujian Medical&#xD;
        Universtiy by two neurolgists&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patients who were diagnosed with NMOSD , and the cell-based assay was used to&#xD;
             determine the AQP4-IgG-seropositive patients;&#xD;
&#xD;
          2. AQP4-IgG is negative in health people with age and sex matching and determined by&#xD;
             cell-based assay;&#xD;
&#xD;
          3. Female or male, age 14-80;&#xD;
&#xD;
          4. Patients or authorized family members volunteered to participate in this study and&#xD;
             signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with coagulation disorders;&#xD;
&#xD;
          2. Infection-related encephalitis;&#xD;
&#xD;
          3. Immune-related encephalitis;&#xD;
&#xD;
          4. A patient with severe mental illness who cannot cooperate clinically;&#xD;
&#xD;
          5. A patient with severe jaundice.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Neurology,First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350005</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 10, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2020</study_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Ning Wang, MD., PhD.</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromyelitis Optica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

